NSIS-B.CO
NSIS-B.CO
DK0060336014
Novonesis (Novozymes A/S) B
Loading chart...

Company Profile

-

Related stocks

DSFIR.AS
DSFIR.AS • Switzerland
DSM FIRMENICH AG
100.65 EUR
27.56B USD 1Y +31.7%
GIVN.SW
GIVN.SW • Switzerland
GIVAUDAN N
3,440 CHF
38.26B USD 1Y +1.9%
EMSN.SW
EMSN.SW • Switzerland
EMS-CHEMIE N
867 CHF
24.43B USD 1Y +50.6%
SY1.DE
SY1.DE • Germany
Symrise AG I
92.24 EUR
14.18B USD 1Y +18.3%
LYB
LYB • Netherlands
LyondellBasell Industries NV
60.03 USD
19.39B USD 1Y +23.9%
SIKA.SW
SIKA.SW • Switzerland
SIKA N
173.8 CHF
33.6B USD 1Y +0.3%
EVK.DE
EVK.DE • Germany
Evonik Industries AG N
21.36 EUR
11.15B USD 1Y +44.2%
BNR.DE
BNR.DE • Germany
Brenntag SE N
62.12 EUR
10.05B USD 1Y +18%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
27.2% p.a.
Max Drawdown (5Y)
-48.5%
Sharpe Ratio (5Y)
-0.10
Beta Factor
0.62
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Strong cyclicality: The business model is sensitive to economic downturns.
Historical Stress Test: Maximum peak-to-trough drawdown of -48.5% in the extended horizon.
ende